NovaBridge Biosciences (NBP) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
NovaBridge Biosciences (NBP) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($13.15 Million) in capital expenditures ($41.00). See NBP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$13.15 Million
USD
Capital Expenditures
$41.00
USD
Data as of
Sep 2025
Most recent filing
NovaBridge Biosciences Capital Reinvestment Ratio (2020–2020)
This chart tracks NovaBridge Biosciences's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for NovaBridge Biosciences (2020–2020)
Year-by-year Capital Reinvestment Ratio for NovaBridge Biosciences from 2020 to 2020. For live market cap and broader valuation context, see NovaBridge Biosciences market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $433.56 Million | $8.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow